Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Recapitulation of developmental mechanisms to revascularize the ischemic heart
Karina N. Dubé, Tonia M. Thomas, Sonali Munshaw, Mala Rohling, Paul R. Riley, Nicola Smart
Karina N. Dubé, Tonia M. Thomas, Sonali Munshaw, Mala Rohling, Paul R. Riley, Nicola Smart
View: Text | PDF
Research Article Cardiology

Recapitulation of developmental mechanisms to revascularize the ischemic heart

  • Text
  • PDF
Abstract

Restoring blood flow after myocardial infarction (MI) is essential for survival of existing and newly regenerated tissue. Endogenous vascular repair processes are deployed following injury but are poorly understood. We sought to determine whether developmental mechanisms of coronary vessel formation are intrinsically reactivated in the adult mouse after MI. Using pulse-chase genetic lineage tracing, we establish that de novo vessel formation constitutes a substantial component of the neovascular response, with apparent cellular contributions from the endocardium and coronary sinus. The adult heart reverts to its former hypertrabeculated state and repeats the process of compaction, which may facilitate endocardium-derived neovascularization. The capacity for angiogenic sprouting of the coronary sinus vein, the adult derivative of the sinus venosus, may also reflect its embryonic origin. The quiescent epicardium is reactivated and, while direct cellular contribution to new vessels is minimal, it supports the directional expansion of the neovessel network toward the infarcted myocardium. Thymosin β4, a peptide with roles in vascular development, was required for endocardial compaction, epicardial vessel expansion, and smooth muscle cell recruitment. Insight into pathways that regulate endogenous vascular repair, drawing on comparisons with development, may reveal novel targets for therapeutically enhancing neovascularization.

Authors

Karina N. Dubé, Tonia M. Thomas, Sonali Munshaw, Mala Rohling, Paul R. Riley, Nicola Smart

×

Figure 4

Endocardial remodeling contributes new subendocardial vessels.

Options: View larger image (or click on image) Download as PowerPoint
Endocardial remodeling contributes new subendocardial vessels.
Detection...
Detection of αSMA+ cells by immunostaining suggested either recruitment of smooth muscle precursors or endothelial-to-mesenchymal transition (A–D, arrowheads in B), consistent with expression of Snai1, in endocardial cells (A). Serial sections, approximately 50 μm apart, revealed progressive closure of subendocardial vessels: in (E), the lumen on the endocardial surface was incompletely enclosed (arrowhead) and only the enclosed side had αSMA support, whereas, in a more apical section (F), the equivalent lumen was fully enclosed (arrowhead) and surrounded by αSMA+ mural cells. Later detection of SM-MHC+ cells, from 7–14 days (arrowheads, G), confirmed a mature smooth muscle phenotype (G). By day 14, some subendocardial vessels were fully enclosed by SM-MHC+ cells (red arrowheads, H; enlarged in I), whereas larger vessels remained devoid of VSMC support (green arrowheads, H; enlarged in J). Scale bars: 100 μm (A–D); 500 μm (E, F, and H); 50 μm (G and J); 10 μm (I). An increase in small/medium SM-MHC+ and SM-MHC– vessels was observed by day 7 and an increase in large SM-MHC+ vessels was observed by day 14. Representative of day 7: n = 15 (4 sham); day 14: n = 5 (2 sham). (K) Vessel count number per 3-mm segment, between endocardium and infarct; sham: n = 4; day 7: n = 8; day 14: n = 8. Box-and-whisker plots show mean ± minimum/maximum. 1-way ANOVA with Bonferroni correction; **P ≤ 0.01, ***P ≤ 0.001 versus sham.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts